Aquestive Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | 11/12/2024 | 9.81 M | $48.86 M | 0.00% | 10.77% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.82 M | $29.00 M | 100.00% | 6.39% |
| VR ADVISER, LLC | 11/14/2024 | 5.56 M | $27.67 M | 0.00% | 6.10% |
| VANGUARD GROUP INC | 11/13/2024 | 4.26 M | $21.23 M | 0.85% | 4.68% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 2.77 M | $13.39 M | -3.07% | 3.04% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 1.80 M | $8.95 M | 100.00% | 1.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.67 M | $8.31 M | 5.74% | 1.83% |
| STATE STREET CORP | 11/14/2024 | 1.50 M | $7.45 M | 52.10% | 1.64% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 1.23 M | $6.10 M | 7.46% | 1.34% |
| JANNEY MONTGOMERY SCOTT LLC | 10/29/2024 | 923,285 | $4.60 M | 4.86% | 1.01% |
| CITADEL ADVISORS LLC | 11/14/2024 | 871,833 | $4.34 M | 419.53% | 0.96% |
| WOODLINE PARTNERS LP | 11/14/2024 | 816,252 | $4.06 M | 35.82% | 0.90% |
| INVESCO LTD. | 11/12/2024 | 786,579 | $3.92 M | 783.39% | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10/10/2024 | 707,078 | $3.52 M | 0.27% | 0.78% |
| MORGAN STANLEY | 11/14/2024 | 671,489 | $3.34 M | 20.77% | 0.74% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 589,561 | $2.94 M | 11.24% | 0.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 429,800 | $2.14 M | 105.25% | 0.47% |
| BRACEBRIDGE CAPITAL, LLC | 11/14/2024 | 428,571 | $2.13 M | 0.00% | 0.47% |
| 11/12/2024 | 400,125 | $1.99 B | 100.00% | 0.44% | |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 282,431 | $1.41 M | -60.67% | 0.31% |
| LATASH INVESTMENTS, LLC | 11/14/2024 | 243,134 | $1.21 M | 0.00% | 0.27% |
| LEGATO CAPITAL MANAGEMENT LLC | 11/07/2024 | 242,371 | $1.21 M | 0.00% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 236,473 | $1.18 M | -69.88% | 0.26% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 222,687 | $1.11 M | 95.32% | 0.24% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 203,540 | $1.01 M | 4.77% | 0.22% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 199,729 | $994,650 | 100.00% | 0.22% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 192,856 | $960,423 | 0.00% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 185,191 | $922,251 | 100.00% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 177,695 | $884,921 | -22.18% | 0.20% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 160,380 | $798,692 | 24.63% | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 155,145 | $772,622 | 6.15% | 0.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 155,032 | $772,059 | 101.81% | 0.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 147,200 | $733,056 | -6.54% | 0.16% |
| CAHILL WEALTH MANAGEMENT, LLC | 11/01/2024 | 142,941 | $711,846 | 20.56% | 0.16% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 137,151 | $683,000 | 525.46% | 0.15% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 133,792 | $666,284 | -2.08% | 0.15% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 130,800 | $651,384 | 100.00% | 0.14% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 108,013 | $537,000 | -0.18% | 0.12% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 11/04/2024 | 107,550 | $535,000 | 100.00% | 0.12% |
| RHUMBLINE ADVISERS | 11/12/2024 | 103,698 | $516,410 | 5.99% | 0.11% |
| BARCLAYS PLC | 11/19/2024 | 99,312 | $495,000 | 285.38% | 0.11% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 95,944 | $477,801 | -75.86% | 0.11% |
| CREATIVE PLANNING | 10/11/2024 | 92,822 | $462,254 | 39.30% | 0.10% |
| UBS GROUP AG | 11/14/2024 | 90,689 | $451,631 | 235.41% | 0.10% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 85,392 | $425,252 | 155.66% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2024 | 75,100 | $373,998 | 22.31% | 0.08% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 68,670 | $341,977 | -70.16% | 0.08% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 67,887 | $338,077 | 100.00% | 0.07% |
| CITADEL ADVISORS LLC | 11/14/2024 | 60,100 | $299,298 | 10.89% | 0.07% |
| BEACON POINTE ADVISORS, LLC | 11/14/2024 | 60,000 | $298,800 | 0.00% | 0.07% |
Aquestive Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 141 institutional investors and hedge funds held shares of Aquestive Therapeutics, Inc.. The most heavily invested institutionals were:
Bratton Capital Management, L.P.: 9.81 M
BlackRock Funding, Inc. /DE: 5.82 M
VR Adviser, LLC: 5.56 M
VANGUARD GROUP INC: 4.26 M
FRANKLIN RESOURCES INC: 2.77 M
BioImpact Capital LLC: 1.8 M
51.35% of Aquestive Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 51.93 M shares in the last 24 months. This purchase volume represents approximately $167.22 M in transactions.